Miguel García‐Grimshaw

Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: A nationwide descriptive study

Miguel García‐Grimshaw, Santa Elizabeth Ceballos‐Liceaga, Laura E. Hernández‐Vanegas et al. · Clinical Immunology · 2021 · 116 citations · Full text

Veterinary Medicine, Infectious Diseases, Neurology +12

Guillain-Barré syndrome is infrequent among recipients of the BNT162b2 mRNA COVID-19 vaccine

Miguel García‐Grimshaw, Anaclara Michel‐Chávez, Juan Mauricio Vera-Zertuche et al. · Clinical Immunology · 2021 · 80 citations · Full text

Veterinary Medicine, Immunology, Neurology +10

Neurologic manifestations in hospitalized patients with COVID-19 in Mexico City

Fernando Flores-Silva, Miguel García‐Grimshaw, Sergio Iván Valdés‐Ferrer et al. · PLoS ONE · 2021 · 67 citations · Full text

Life Sciences, Infectious Diseases, Neurology +15

Epidemiological and clinical characteristics of patients with human monkeypox infection in Mexico: a nationwide observational study

Isaac Núñez, Miguel García‐Grimshaw, Santa Elizabeth Ceballos‐Liceaga et al. · The Lancet Regional Health - Americas · 2022 · 64 citations · Full text

Veterinary Medicine, Infectious Diseases, Infectious Disease Epidemiology +12

Bilateral Thalamic Ischemic Stroke Secondary to Occlusion of the Artery of Percheron

Miguel García‐Grimshaw, Mariana Peschard-Franco, Francisco Alejandro Gutiérrez-Manjarrez · Cureus · 2018 · 32 citations · Full text

Life Sciences, Neurology, Neuroscience +15